首页> 外文期刊>Human mutation >A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2.
【24h】

A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2.

机译:诊断遗传测试,对易感性乳腺癌基因BRCA1和BRCA2中种系重排进行物理定位。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The BRCA1 and BRCA2 genes are involved in breast and ovarian cancer susceptibility. About 2 to 4% of breast cancer patients with positive family history, negative for point mutations, can be expected to carry large rearrangements in one of these two genes. We developed a novel diagnostic genetic test for the physical mapping of large rearrangements, based on molecular combing (MC), a FISH-based technique for direct visualization of single DNA molecules at high resolution. We designed specific Genomic Morse Codes (GMCs), covering the exons, the noncoding regions, and large genomic portions flanking both genes. We validated our approach by testing 10 index cases with positive family history of breast cancer and 50 negative controls. Large rearrangements, corresponding to deletions and duplications with sizes ranging from 3 to 40 kb, were detected and characterized on both genes, including four novel mutations. The nature of all the identified mutations was confirmed by high-resolution array comparative genomic hybridization (aCGH) and breakpoints characterized by sequencing. The developed GMCs allowed to localize several tandem repeat duplications on both genes. We propose the developed genetic test as a valuable tool to screen large rearrangements in BRCA1 and BRCA2 to be combined in clinical settings with an assay capable of detecting small mutations.
机译:BRCA1和BRCA2基因与乳腺癌和卵巢癌的易感性有关。家族史阳性,点突变阴性的乳腺癌患者中,大约有2-4%会在这两个基因之一中发生较大的重排。我们基于分子梳理(MC)(一种基于FISH的技术,可在高分辨率下直接可视化单个DNA分子)开发了一种用于大型重排的物理作图的新颖诊断基因测试。我们设计了特定的基因组摩尔斯电码(GMC),涵盖了外显子,非编码区和两个基因侧翼的大型基因组部分。我们通过测试10例阳性乳腺癌家族史和50例阴性对照的病例来验证我们的方法。在两个基因上检测到并表征了大的重排,对应于大小为3至40 kb的缺失和重复,包括四个新突变。通过高分辨率阵列比较基因组杂交(aCGH)和以测序为特征的断点,确认了所有已鉴定突变的性质。发达的GMC可以在两个基因上定位多个串联重复重复序列。我们建议将开发的基因测试作为筛选BRCA1和BRCA2中大型重排的宝贵工具,以在临床环境中结合能够检测小突变的测定法进行组合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号